Reported by COINOTAG News on September 17, Nasdaq-listed Hoth Therapeutics said its board approved an update to the company’s cryptocurrency treasury strategy, permitting purchases of Ethereum and Solana alongside Bitcoin. The firm previously announced a $1 million allocation intended for Bitcoin; the board indicated that this capital will now be deployed to acquire BTC, ETH and SOL as part of a disciplined reallocation to diversify the company’s balance sheet. The decision reflects a tactical shift in treasury allocation and underscores a focus on liquidity management and measured digital asset exposure rather than speculative positioning, consistent with corporate governance and risk oversight practices.